HUM vs UNH
Humana Inc. and Unitedhealth Group Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | HUM | UNH |
|---|---|---|
| Revenue | $129.7B | $447.6B |
| Net income | $1.2B | $12.1B |
| Gross margin | — | 88.7% |
| Net margin | 0.9% | 2.9% |
| Return on equity | 7.0% | 12.2% |
| Diluted EPS | $9.84 | $13.23 |
| Dividend / share | $3.54 | $8.73 |
| Payout ratio | 36.2% | 65.7% |
| Free cash flow | $375.0M | $16.1B |
| Equity | $17.7B | — |
| Net debt / equity | 0.46× | 0.54× |
| Current ratio | 2.00× | 0.79× |
| Revenue CAGR 5y | 10.9% | 11.7% |
| Profit CAGR 5y | −18.8% | −4.8% |
UNH bills 3.5× the revenue of HUM, and keeps more of each dollar of revenue as profit (2.9% against 0.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | HUM | UNH |
|---|---|---|
| FY2025 | $129.7B | $447.6B |
| FY2024 | $117.8B | $400.3B |
| FY2023 | $106.4B | $371.6B |
| FY2022 | $92.9B | $324.2B |
| FY2021 | $83.1B | $287.6B |
| FY2020 | $77.2B | $257.1B |
| FY2019 | $64.9B | $242.2B |
| FY2018 | $56.9B | $226.2B |
| FY2017 | $53.8B | $201.2B |
| FY2016 | $54.4B | $184.8B |
Net income by year
Bottom line
| Fiscal year | HUM | UNH |
|---|---|---|
| FY2025 | $1.2B | $12.1B |
| FY2024 | $1.2B | $14.4B |
| FY2023 | $2.5B | $22.4B |
| FY2022 | $2.8B | $20.1B |
| FY2021 | $2.9B | $17.3B |
| FY2020 | $3.4B | $15.4B |
| FY2019 | $2.7B | $13.8B |
| FY2018 | $1.7B | $12.0B |
| FY2017 | $2.4B | $10.6B |
| FY2016 | $614.0M | $7.0B |